Effects of allopurinol on endothelial dysfunction: A meta-analysis

American Journal of Nephrology

Volumn 39, Issue 4, 2014, Pages 348-356

  Kanbay, Mehmet ^a   Siriopol, Dimitrie ^b   Nistor, Ionut ^b   Elcioglu, Omer C ^a   Telci, Ozge ^a   Takir, Mumtaz ^a   Johnson, Richard J ^c   Covic, Adrian ^b  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Allopurinol; Cardiovascular disease; Endothelial dysfunction; Uric acid

Indexed keywords

ACETYLCHOLINE; ALLOPURINOL; NITROPRUSSIDE SODIUM; URIC ACID; ANTIGOUT AGENT;

ENDOTHELIAL DYSFUNCTION; FOREARM BLOOD FLOW; HUMAN; HYPERURICEMIA; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; COCHRANE LIBRARY; EMBASE; MEDLINE; SCOPUS; CARDIOVASCULAR DISEASES; DRUG EFFECTS; VASCULAR ENDOTHELIUM;

ALLOPURINOL; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; GOUT SUPPRESSANTS; HUMANS; HYPERURICEMIA; VASODILATION;

EID: 84898675778     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000360609     Document Type: Review

References (48)

1. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH: Hyperuricemia in primary and renal hypertension. N Engl J Med 1966; 275: 457-464
2. Tuttle KR, Short RA, Johnson RJ: Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 2001; 87: 1411-1414
3. Lehto S, Niskanen L, Ronnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29: 635-639
4. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, et al: Serum uric acid and brain ischemia in normal elderly adults. Neurology 2007; 69: 1418-1423
5. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, et al: Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005; 46: 1263-1269
6. Siu YP, Leung KT, Tong MK, Kwan TH: Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51-59
7. Grayson PC, Kim SY, LaValley M, Choi HK: Hyperuricemia and incident hypertension: A systematic review and meta-Analysis. Arthritis Care Res (Hoboken) 2011; 63: 102-110
8. Feig DI, Madero M, Jalal DI, Sanchez-Lozada LG, Johnson RJ: Uric acid and the origins of hypertension. J Pediatr 2013; 162: 896-902
9. Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, et al: Effects of uric acidlowering therapy on renal outcomes: A systematic review and meta-Analysis. Nephrol Dial Transplant 2014; 29: 406-413
10. Johnson RJ, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E: Uric acid and chronic kidney disease: Which is chasing which?. Nephrol Dial Transplant 2013; 28: 2221-2228
11. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al: Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009; 32: 1737-1742
12. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al: Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013; 62: 3307-3315
13. Stam F, Van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, et al: Endothelial dysfunction contributes to renal function-Associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn study. J Am Soc Nephrol 2006; 17: 537-545
14. Endemann DH, Schiffrin EL: Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-1992
15. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, et al: Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005; 59: 1276-1282
16. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al: Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004; 94: 932-935
17. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F: Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006; 17: 1466-1471
18. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al: Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742
19. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN: Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 2008; 27: 967-978
20. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ: Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293:C584-C596
21. Sanchez-Lozada LG, Rivard C, Lanaspa M, Roncal C, Franco M, Sautin Y, et al: Uric acid alters mitochondrial biogenesis in cultured human endothelial cells. Am Soc Nephrol Annual Meeting, 2009, abstract
22. Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562
23. Schwartz IF, Grupper A, Chernichovski T, Hillel O, Engel A, Schwartz D: Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats. J Vasc Res 2011; 48: 252-260
24. Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, et al: Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol 2012; 77: 275-282
25. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, et al: A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 2011; 6: 1887-1894
26. Goicoechea M, De Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, et al: Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010; 5: 1388-1393
27. Meléndez-Ramirez G, Perez-Mendez O, Lopez-Osorio C, Kuri-Alfaro J, Espinola-Zavaleta N: Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia. Endocr Res 2012; 37: 1-6
28. Dogan A, Yarlioglues M, Kaya MG, Karadag Z, Dogan S, Ardic I, et al: Effect of long-Term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Press 2011; 20: 182-187
29. Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, et al: Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome. Clin Res Cardiol 2008; 97: 334-340
30. George J, Carr E, Davies J, Belch JJ, Struthers A: High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006; 114: 2508-2516
31. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E, Miller N: Allopurinol improves endothelial function in sleep apnoea: A randomised controlled study. Eur Respir J 2006; 27: 997-1002
32. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD: Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002; 106: 221-226
33. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, et al: Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: Results from two placebo-controlled studies. Circulation 2002; 105: 2619-2624
34. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746-751
35. O'Driscoll JG, Green DJ, Rankin JM, Taylor RR: Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects. Clin Exp Pharmacol Physiol 1999; 26: 779-783
36. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 1996; 17: 1-12
37. Higgins JPT: Green S (eds): Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011
38. Review Manager (RevMan): Version 5.2. Copenhagen, The Nordic Cochrane Centre/The Cochrane Collaboration, 2012
39. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A: Meta-Analyses involving cross-over trials: Methodological issues. Int J Epidemiol 2002; 31: 140-149
40. Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
41. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115
42. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
43. Vita JA: Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol 2002; 359: 186-200
44. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML: Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-Angiotensin system. J Hypertens 2008; 26: 269-275
45. Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH: Oxidative stress with an activation of the renin-Angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010; 28: 1234-1242
46. Sanchez-Lozada LG, Lanaspa MA, Cristobal-Garcia M, Garcia-Arroyo F, Soto V, Cruz-Robles D, et al: Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol 2012; 121:e71-e78
47. Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, et al: Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 2008; 295:C1183-C1190
48. Waring WS, McKnight JA, Webb DJ, Maxwell SR: Lowering serum urate does not improve endothelial function in patients with type 2 diabetes. Diabetologia 2007; 50: 2572-2579